Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Anabolic steroid users may face higher risk of severe COVID-19.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

There's no significant genetic link between male pattern baldness and COVID-19.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

A new teledermatology system improved access and reduced wait times for skin care.

No significant link between male pattern baldness and COVID-19 severity was found.

Covid-19 affected asthmatic patients in Western Saudi Arabia.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Testosterone may influence COVID-19 severity and outcomes.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

COVID-19 vaccination may trigger lupus in some people.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

COVID-19 can cause skin problems.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Long COVID causes lasting symptoms and needs ongoing care.